Niacin's role in maintaining good cholesterol

June 5, 2008

A research team has uncovered the likely target of niacin (vitamin B3) in the liver, which should provide a clearer picture of how this vitamin helps maintain adequate HDL-cholesterol levels in the blood and thus lower the risk of heart disease.

While niacin can increase plasma HDL levels, the mechanism of how it works has been mysterious, although it's believed that niacin does not actually increase HDL production. Recent work had uncovered that a component of ATP synthase (the protein that makes ATP) is present on the surface of liver cells, and this subunit known as the 'beta chain' can take up HDL.

Now, Moti Kashyap and colleagues found that this beta chain is the basis of niacin's effect. They added niacin to samples of human liver cells and found that treatment reduced the presence of Beta chain on the cell surface by ~27%, and as a result HDL uptake was reduced by ~35%. In comparison, nicotinamide, a related molecule with no clinical benefit, had far weaker effects.

These results indicate niacin hinders the liver from removing HDL from the blood, thus maintaining high plasma HDL levels. Importantly, niacin does not affect another major pathway known as "Reverse Cholesterol Transport." Therefore, it maintains HDL levels while still allowing the removal of other cholesterol types, explaining why niacin is especially beneficial.

The work also identifies a new drug target, as no other drug in currently known to raise HDL by inhibiting the surface expression of the beta chain of ATP synthase.

Source: American Society for Biochemistry and Molecular Biology

Explore further: Niacin added to statin therapy increases HDL cholesterol levels but does not improve HDL functionality, research shows

Related Stories

Niacin too dangerous for routine cholesterol therapy

July 16, 2014

After 50 years of being a mainstay cholesterol therapy, niacin should no longer be prescribed for most patients due to potential increased risk of death, dangerous side effects and no benefit in reducing heart attacks and ...

HDL: Not so 'good' after all?

August 28, 2012

After years of having it drilled into their heads, most people now know that LDL (low-density lipoprotein) is the "bad" cholesterol package that increases the risk of cardiovascular disease, and HDL (high-density lipoprotein) ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

tao53nyc
3 / 5 (1) Jun 05, 2008
Why would I care about a "new drug target" when I can just continue taking niacin? I've known about niacin's benefits over 20 years.
vanderMerwe
3 / 5 (1) Jun 06, 2008
I've known about niacin and HDL for some time. I've worried about taking the sorts of dosage levels recommended in that I've also read that the dosage levels required are close to those that can trigger a toxic effect for the liver.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.